These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 129512)
1. [Clinical evaluation of a new anti-inflammatory agent in the field of otorhinolaryngology]. Roux O JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1975 Sep; 24(7):545-7. PubMed ID: 129512 [No Abstract] [Full Text] [Related]
2. [Esfar in an ENT department]. Traissac L; Pasquet J Rev Laryngol Otol Rhinol (Bord); 1976; 97(3-4):177-9. PubMed ID: 1034331 [No Abstract] [Full Text] [Related]
3. [Calcium bucloxate: its use in ORL inflammatory pathology]. Gaillard J; Dumolard P JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1975 Feb; 24(2):153-5. PubMed ID: 123947 [No Abstract] [Full Text] [Related]
4. [Evaluation of the therapeutic activity and tolerability of difenpiramide in otorhinolaryngology]. Lunghi F; Blasi M; Frasson P; Lunghi M; Giusti P Clin Ter; 1982 Dec; 103(6):635-45. PubMed ID: 7160146 [No Abstract] [Full Text] [Related]
5. [Note on a new anti-inflammatory agent in otorhinolaryngology]. Lacher G Rev Laryngol Otol Rhinol (Bord); 1968; 89(7):499-501. PubMed ID: 5715348 [No Abstract] [Full Text] [Related]
6. [Use of a new antalgic anti-inflammatory agent in otorhinolaryngology]. Portmann M; Pardes P Rev Laryngol Otol Rhinol (Bord); 1971; 92(3):235-8. PubMed ID: 5565287 [No Abstract] [Full Text] [Related]
7. [Clinical study of the analgesic and anti-inflammatory activity of AF-864 (benzydamine hydrochloride) in otorhinolaryngology]. Di Fede S Policlinico Prat; 1966 Nov; 73(46):1540-5. PubMed ID: 5998755 [No Abstract] [Full Text] [Related]
8. [Consensus conference on the rationale for use of anti-inflammatory agents in otorhinolaryngology]. Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):5-40. PubMed ID: 15462021 [No Abstract] [Full Text] [Related]
9. [Thromboembolic disease of long standing with hyperfibrinogenemia. Treatment with heparin, magnesium and anti-inflammatory agent]. Cristau P; Hainaut J; Molinie C; Essioux H; Pariente A; Florent C; Laverdant C Ann Med Interne (Paris); 1977 Nov; 128(11):887-94. PubMed ID: 563206 [No Abstract] [Full Text] [Related]
10. [ENT clinical study of a new anti-inflammatory drug: Imotryl]. Garcin M; Gola R J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1971 Mar; 20(3):547-8. PubMed ID: 4267911 [No Abstract] [Full Text] [Related]
11. [Results and considerations in the use of an anti-inflammatory and analgesic preparation in otorhinolaryngology]. Girardi G Minerva Med; 1967 Apr; 58(32):1487-9. PubMed ID: 6029515 [No Abstract] [Full Text] [Related]
12. [Rhinoparyl in otorhinolaryngology]. Flottes L; Riu R; Le Mouel C Rev Laryngol Otol Rhinol (Bord); 1965; 86(9):772-88. PubMed ID: 5851575 [No Abstract] [Full Text] [Related]
13. [Anti-inflammatory enzyme used in otorhinolaryngology]. Kagitomi T Nihon Jibiinkoka Gakkai Kaiho; 1972 Dec; 75(12):1463-4. PubMed ID: 4675769 [No Abstract] [Full Text] [Related]
14. [Advantages of a painless and colorless topical agent in otorhinolaryngology]. Appaix A; Dinand F; Houel B Mars Med; 1971; 108(1):79-81. PubMed ID: 4323276 [No Abstract] [Full Text] [Related]
15. [83-75 C in otorhinolaryngology]. Mounier-Kuhn P; Lapicorey G Sem Hop; 1965 Jun; 41(31):1891-2. PubMed ID: 4284874 [No Abstract] [Full Text] [Related]